Repetitive Thoughts and Behavior in Pervasive Developmental Disorders: Treatment with Serotonin Reuptake Inhibitors

Results from two studies indicate the nonselective serotonin reuptake inhibitor (SRI) clomipramine is more efficacious than the relatively selective norepinephrine reuptake inhibitor desipramine and placebo in children with autism. A study of the selective SRI fluvoxamine found it to be significantl...

Full description

Saved in:
Bibliographic Details
Published inJournal of autism and developmental disorders Vol. 30; no. 5; pp. 427 - 438
Main Authors McDougle, Christopher J, Kresch, Laura E, Posey, David J
Format Journal Article
LanguageEnglish
Published United States Springer Nature B.V 01.10.2000
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Results from two studies indicate the nonselective serotonin reuptake inhibitor (SRI) clomipramine is more efficacious than the relatively selective norepinephrine reuptake inhibitor desipramine and placebo in children with autism. A study of the selective SRI fluvoxamine found it to be significantly better than placebo for reducing repetitive phenomena and aggression. (Contains references.) (Author/CR)
Bibliography:Special Issue: Treatments for People with Autism and Other Pervasive Developmental Disorders: Research Perspectives.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0162-3257
1573-3432
DOI:10.1023/a:1005551523657